Company profile: Corvia Medical
1.1 - Company Overview
Company description
- Provider of transcatheter structural heart devices for heart failure, including the Corvia Atrial Shunt (InterAtrial Shunt Device) designed to treat diastolic heart failure/HFpEF by reducing pressures in the heart and lungs, supported by clinical evidence and the RESPONDER-HF clinical study assessing efficacy in patients with EF ≥40%.
Products and services
- Corvia Atrial Shunt: Transcatheter interatrial shunt device (IASD) engineered for HFpEF/DHF therapy, lowers cardiac and pulmonary pressures to alleviate symptoms and potentially slow progression of heart failure
- Clinical Evidence: Clinical-trial-supported documentation cataloguing the Corvia Atrial Shunt’s safety and effectiveness, aggregating results from structured studies in heart failure to substantiate device performance
- RESPONDER-HF Clinical Study: EF ≥40%-specified clinical trial evaluating the Corvia Atrial Shunt’s efficacy in heart failure patients, generating outcome data on device impact in this defined ejection fraction cohort
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Corvia Medical
EKOS
HQ: United States
Website
- Description: Provider of ultrasound-accelerated thrombolysis systems for the treatment of vascular thrombosis. Its EKOS EkoSonic Endovascular System, introduced in 2005, is used by interventional radiologists, cardiologists, and vascular surgeons at leading institutions worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EKOS company profile →
InterValve
HQ: United States
Website
- Description: Provider of catheter-based medical devices for treating calcified aortic valve stenosis, developing tools for percutaneous and trans-apical aortic valve replacement. Products include the V8 Aortic Valvuloplasty Balloon Catheter, featuring a figure-8 balloon to lock into valve anatomy and optimize dilation, and the TAV8, which maintains the V8 design with enhancements to reduce procedure time and conduction disturbances.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InterValve company profile →
Phraxis
HQ: United States
Website
- Description: Provider of medical devices enabling vascular access for hemodialysis, including EndoForce, a transcatheter-delivered endovascular anastomotic connector designed for coaxial anastomosis of a vein to an arteriovenous graft, featuring a flexible nitinol segment, a rigid segment for radial force, and nitinol anchoring barbs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phraxis company profile →
Veryan Medical
HQ: United Kingdom
Website
- Description: Provider of three-dimensional Nitinol vascular stents for peripheral arterial disease, including the BioMimics 3D Vascular Stent System, a self-expanding stent with 3D helical geometry designed to impart a gentle helical shape to the stented artery to provoke swirling flow, increase wall shear stress, reduce intimal hyperplasia, improve biomechanical compatibility, and reduce stent fracture risk, and the MIMICS clinical program (MIMICS-RCT, MIMICS-2, MIMICS-3D) evaluating safety, effectiveness, and performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veryan Medical company profile →
WhiteSwell
HQ: Ireland
Website
- Description: Provider of science-driven solutions to improve treatment of acute decompensated heart failure, addressing a leading cause of hospitalization and emergency room visits by investigating the therapeutic potential of the lymphatic system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WhiteSwell company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Corvia Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Corvia Medical
2.2 - Growth funds investing in similar companies to Corvia Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Corvia Medical
4.2 - Public trading comparable groups for Corvia Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →